Cequa
Generic name: Cyclosporine Ophthalmic
Brand names: Cequa
Drug class:
Ophthalmic anti-inflammatory agents
Usage of Cequa
Cequa is an immunosuppressant. Cequa can increase tear production that has been reduced by inflammation in the eye(s).
Cequa is used to treat chronic dry eye that may be caused by inflammation.
Cequa eye drops are packaged in sterile, preservative-free, single-use vials.
Cequa side effects
Get emergency medical help if you have signs of an allergic reaction to Cequa: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using Cequa and call your doctor at once if you have:
Common Cequa side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Cequa
You should not use Cequa if you are allergic to cyclosporine.
Tell your doctor if you are pregnant or breastfeeding.
Cequa is not approved for use by anyone younger than 16 years old.
Relate drugs
- Acular
- Acular LS
- Acular PF
- Acuvail
- Cyclosporine ophthalmic
- Bromday
- Bromfenac
- Bromfenac ophthalmic
- Bromsite
- BromSite ophthalmic
- Cequa
- Diclofenac ophthalmic
- Flurbiprofen ophthalmic
- Ketorolac ophthalmic
- Lifitegrast
- Lifitegrast ophthalmic
- Miebo
- Nepafenac
- Nevanac
- Ocufen
- Perfluorohexyloctane
- Prolensa
- Prolensa ophthalmic
- Restasis
- Restasis MultiDose
- Verkazia
- Vevye
- Voltaren (Diclofenac Ophthalmic)
- Xibrom
- Xiidra
How to use Cequa
Usual Adult Dose for Keratoconjunctivitis Sicca:
1 drop 2 times a day in each eye approximately 12 hours apart Comments: -This drug can be used concomitantly with artificial tears, allowing a 15 minute interval between products. Use: To increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca
Warnings
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
What other drugs will affect Cequa
Medicine used in the eyes is not likely to be affected by other drugs you use. But many drugs can interact with each other. Tell each of your healthcare providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.
Popular FAQ
Cequa is not covered by most insurance plans as less expensive alternatives are now available for chronic dry eye. A similar generic cyclosporine eye drop is now available at US pharmacies and may be preferred by your insurance company. If you prefer brand name Cequa, your cost with Medicare will depend upon your specific insurance coverage. If you have commercial insurance, you may be eligible for a copay card from Sun Ophthalmics.
Yes, the Cequa copay card is available from Sun Ophthalmics by calling 1-855-268-1426 or accessing online. Present the activated copay card to your pharmacist with a valid prescription. If you have commercial health insurance and are a US resident, you may pay as little as $0 per month for each 60 vial box of Cequa. The maximum benefit is $250 per prescription.
Cequa is expensive because it was approved in 2018 and is not yet available as a generic. Cequa also uses a special nanomicellar technology to help deliver poorly water-soluble drugs into the eye. The generic for Cequa may not be available for many years due to patent protection. There are other options: the manufacturer offers a copay card if you are eligible that may reduce your Cequa cost to $0, or a generic cyclosporine eye drop option for Restasis is available. Talk to your doctor.
Both Cequa and Restasis are eye drops that contain cyclosporine. They are used to increase tear production in patients with dry eye disease (medically called keratoconjunctivitis sicca). However, Cequa incorporates a novel nanomicellar technology of cyclosporine A to allow delivery of high concentrations of the medication into the eye. Restasis is not manufactured using nanomicellar technology. Nanomicellar technology can help deliver poorly water-soluble drugs into the eye and protect the drug molecule. Continue reading
Cequa is not covered by most insurance plans as less expensive alternatives are now available for chronic dry eye. A similar generic cyclosporine eye drop is now available at US pharmacies and may be preferred by your insurance company. If you prefer brand name Cequa, your cost with Medicare will depend upon your specific insurance coverage. If you have commercial insurance, you may be eligible for a copay card from Sun Ophthalmics.
Yes, the Cequa copay card is available from Sun Ophthalmics by calling 1-855-268-1426 or accessing online. Present the activated copay card to your pharmacist with a valid prescription. If you have commercial health insurance and are a US resident, you may pay as little as $0 per month for each 60 vial box of Cequa. The maximum benefit is $250 per prescription.
Cequa is expensive because it was approved in 2018 and is not yet available as a generic. Cequa also uses a special nanomicellar technology to help deliver poorly water-soluble drugs into the eye. The generic for Cequa may not be available for many years due to patent protection. There are other options: the manufacturer offers a copay card if you are eligible that may reduce your Cequa cost to $0, or a generic cyclosporine eye drop option for Restasis is available. Talk to your doctor.
Both Cequa and Restasis are eye drops that contain cyclosporine. They are used to increase tear production in patients with dry eye disease (medically called keratoconjunctivitis sicca). However, Cequa incorporates a novel nanomicellar technology of cyclosporine A to allow delivery of high concentrations of the medication into the eye. Restasis is not manufactured using nanomicellar technology. Nanomicellar technology can help deliver poorly water-soluble drugs into the eye and protect the drug molecule. Continue reading
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions